
Lifestyle Management Uplifted in 2017 ADA Diabetes Care Standards
The recommendation to limit long periods of sitting comes after multiple studies show how it affects blood glucose management. ADA also gives providers charts to help them understand the cost of different therapies.
Move every 30 minutes during prolonged periods of sitting. Give older adults balance and flexibility training. Pay more attention to sleep patterns, given their known effect on blood sugar levels.
These recommendations and others occupy an entire section of the
ADA’s recommendations come as CMS is moving forward with payment models that fit this approach. CMS has taken the first steps toward paying for the
Cost of Care. The ADA also took a step to help providers navigate costs: the 2017 standards feature 2 tables that estimate average monthly costs for insulin and non-insulin therapies. Last month, the ADA publicly called on Congress to investigate the
Key scientific news in the ADA Standards is the report, “Differentiation of Diabetes by Pathophysiology, Natural History, and Prognosis,” which was published in ADA’s journal, Diabetes.2 The report was produced at a symposium of the ADA, the JDRF, European Association for the Study of Diabetes, and the American Association of Endocrinologists. According to a
“The expert consensus is that unifying characteristics of the vast majority of diabetes is hyperglycemia, resulting from β-cell destruction of dysfunction,” Robert E. Ratner, MD, FACP, FACE, chief scientific officer for ADA, said in the statement. “With a better understanding of how various factors affect the number and function of β-cells, we may be able to classify subtypes of the diseases, predict the rate of progression and identify where and how interventions can be targeted to prevent or delay disease progression and complications.”
Lifestyle Management. Changes here are so substantial that the section was renamed from, “Foundations of Care and Comprehensive Medical Evaluation.” An important change comes in the opening section on Diabetes Self-Management Education and Support (DSMES), which states that, “There is growing evidence for the role of community health workers, as well as peer and lay leaders, in providing ongoing support.”
The need for diabetes education to continue as the disease changes, not a “once and done” approach, is the subject of the current special issue of
In recent years, multiple studies have taken aim at the harms of sitting for extended periods, the most recent one coming just this month in
With the new recommendations, ADA has endorsed this approach. The 2017 standards say that “all individuals, including those with diabetes, should be encouraged to reduce the amount of time spent being sedentary (e.g., working at a computer, watching TV), by breaking up bouts of sedentary activity (>30 minutes) by briefly standing, walking, or performing at other light physical activities.” Doing so could help prevent T2D in those at risk or improve glycemic control in those already diagnosed, the statement says.
How this recommendation is received in workplaces remains to be seen, but ADA has given payers who work with employers a new tool in designing work stations or policies that confront chronic disease.
The 2017 standards include ADA’s recent call to integrate
Studies have found that
Treatment Updates. The 2017 Standards reflect recommendations in the June 2016 issue of Diabetes Care for
ADA formally recommends 2 therapies for control of diabetes and cardiovascular (CV) disease, which includes those who have suffered a stroke or heart attack, acute coronary syndrome, angina, or peripheral artery disease. Empagliflozin, the sodium-glucose co-transporter-2 inhibitor sold as Jardiance, and liraglutide, the glucagon-like peptide-1 sold as Victoza, have both been shown in clinical trials to have CV benefits. However, ADA is not ready to extend this recommendation to other drugs in the GLP-1 or SGLT2 classes without more research.
Empagliflozin just received a new
References
1. American Diabetes Association. Standards of Medical Care in Diabetes--2017. [published online December 15, 2016]. Diabetes Care. 2017; 40(suppl1). S1-S135.
2. Skyler JS, Bakris GL, Bonifacio E, et al. Differentiation of diabetes by pathophysiology, natural history and prognosis [published online December 15, 2016]. Diabetes.
Newsletter
Stay ahead of policy, cost, and value—subscribe to AJMC for expert insights at the intersection of clinical care and health economics.